Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2001
08/02/2001DE10001230A1 Immunisierungsmittel Immunizing agent
08/02/2001CA2786722A1 Enhanced production of lipids containing polyenoic fatty acids by high density cultures of eukaryotic microbes in fermentors
08/02/2001CA2760879A1 Enhanced production of lipids containing polyenoic fatty acids by high density cultures of eukaryotic microbes in fermentors
08/02/2001CA2423122A1 Closure of bacterial ghosts
08/02/2001CA2399109A1 T cell receptor libraries
08/02/2001CA2398791A1 Human membrane proteins and polynucleotides encoding the same
08/02/2001CA2398790A1 Methods of identifying synthetic transcriptional and translational regulatory elements, and compositions relating to same
08/02/2001CA2398786A1 Molecule transferring device, auxiliary for molecule transferring device, and molecule transferring method
08/02/2001CA2398743A1 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1
08/02/2001CA2398660A1 Human cyr61
08/02/2001CA2398633A1 Identifying genes associated with a qtl corn digestibility locus
08/02/2001CA2398611A1 Vaccine for the prophylactic or therapeutic immunization against hiv
08/02/2001CA2398564A1 Nuclear hormone receptors
08/02/2001CA2398563A1 Modulation of gene expression in formation of fatty atherosclerotic lesions
08/02/2001CA2398548A1 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
08/02/2001CA2398546A1 Methods and materials relating to cd84-like polypeptides and polynucleotides
08/02/2001CA2398541A1 Synthetic internal ribosome entry sites and methods of identifying same
08/02/2001CA2398462A1 Transgenic plant-based vaccines
08/02/2001CA2398430A1 Human protein kinases and protein kinase-like enzymes
08/02/2001CA2398411A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2398407A1 Isolated polynucleotide encoding a novel phosphate transporter in plants and a method of modulating phosphate uptake in plants
08/02/2001CA2398396A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
08/02/2001CA2398284A1 Methods and compositions for generating human monoclonal antibodies
08/02/2001CA2398271A1 Compositions and methods for performing biological reactions
08/02/2001CA2398242A1 Fil-1 theta dnas and polypeptides
08/02/2001CA2398227A1 17 human secreted proteins
08/02/2001CA2398139A1 Proteins comprising conserved regions of neisseria meningitidis surface antigen nhha
08/02/2001CA2398104A1 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications
08/02/2001CA2398003A1 Phosphodiesterases
08/02/2001CA2397839A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2397735A1 Use of a nucleotide sequence for enhancing protein synthesis and expression of proteins
08/02/2001CA2397643A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof
08/02/2001CA2397532A1 Recombinant aav packaging systems
08/02/2001CA2397407A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2397267A1 Peptide fragments and uses thereof as type-1 interferon antagonist
08/02/2001CA2397186A1 Gene cluster for everninomicin biosynthesis
08/02/2001CA2396893A1 Devices and methods for biochip multiplexing
08/02/2001CA2396884A1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants
08/02/2001CA2396709A1 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
08/02/2001CA2396454A1 Recombinant attenuation of prrsv
08/02/2001CA2395885A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395872A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395858A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395857A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395832A1 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
08/02/2001CA2395827A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395816A1 Nucleic acids, proteins and antibodies
08/02/2001CA2395811A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395794A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395787A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395734A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395693A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395676A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395671A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395666A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395654A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395403A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395398A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395295A1 Nucleic acids, proteins and antibodies
08/02/2001CA2395178A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2394841A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2394411A1 Method of processing a sample containing at least one biological element
08/02/2001CA2394332A1 Chimeric neuropeptide y receptors
08/02/2001CA2394039A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2393954A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2393941A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2393912A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2393652A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2393618A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2393616A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2393002A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2392757A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2392751A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2392438A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2392428A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2392422A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2392398A1 Nucleic acids, proteins, and antibodies
08/01/2001EP1120655A2 A method for detecting an aberrant animal-derived prion gene and prion gene modified mouse which exhibits heart anomalies
08/01/2001EP1120646A1 Method for detecting single nucleotide polymorphism (snp) and point mutation in gene, detection apparatus and detection chip
08/01/2001EP1120643A2 Device for detecting fluorescent light of several sample points
08/01/2001EP1120469A2 Method for actively transporting DNA
08/01/2001EP1120466A2 Use of negative regulation elements for nerve-specific expression of transgenes
08/01/2001EP1120465A1 D-Aminoacylase and gene encoding the same
08/01/2001EP1120464A2 Stabilizing peptides, polypeptides and antibodies which include them
08/01/2001EP1120463A1 Apoptin-associating protein
08/01/2001EP1120461A1 Process for producing copolymerized polyester
08/01/2001EP1120426A1 Novel g protein-coupled receptors
08/01/2001EP1120425A1 Process for eliminating n-terminal methionine
08/01/2001EP1120157A2 Self-addressable electronic device
08/01/2001EP1120156A2 Method of electronically controlled hybridization of DNA
08/01/2001EP1120155A2 Method for combinatorial synthesis of a biopolymer
08/01/2001EP1119772A1 A novel ret-independent signaling pathway for gdnf
08/01/2001EP1119643A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF TUMOR NECROSIS FACTOR-$g(a) (TNF-$g(a)) EXPRESSION
08/01/2001EP1119642A1 Compounds and methods for enhancing delivery of free polynucleotide
08/01/2001EP1119633A2 Commercial production of laccase in plants
08/01/2001EP1119632A1 Hypersensitive response elicitor from xanthomonas campestris
08/01/2001EP1119631A2 Transgene assay using stable agrobacterium rhizogenes transformation
08/01/2001EP1119630A1 Nucleic acid constructs for genetic immunisation
08/01/2001EP1119629A2 Oxidoreductase molecules
08/01/2001EP1119628A2 Dna sequences for enzymatic synthesis of polyketide or heteropolyketide compounds